Literature DB >> 31346092

A deep intronic splice mutation of STAT3 underlies hyper IgE syndrome by negative dominance.

Joëlle Khourieh1,2, Geetha Rao3, Tanwir Habib4, Danielle T Avery3, Alain Lefèvre-Utile1,2, Marie-Olivia Chandesris2,5, Aziz Belkadi1,2, Maya Chrabieh1,2, Hanan Alwaseem6, Virginie Grandin7, Françoise Sarrot-Reynauld8, Agathe Sénéchal9, Olivier Lortholary2,10,11, Xiao-Fei Kong12, Stéphanie Boisson-Dupuis1,2,12, Capucine Picard1,2,5,7, Anne Puel1,2,12, Vivien Béziat1,2,12, Qian Zhang12, Laurent Abel1,2,12, Henrik Molina6, Nico Marr4,13, Stuart G Tangye3,14, Jean-Laurent Casanova15,2,5,12,16, Bertrand Boisson15,2,12.   

Abstract

Heterozygous in-frame mutations in coding regions of human STAT3 underlie the only known autosomal dominant form of hyper IgE syndrome (AD HIES). About 5% of familial cases remain unexplained. The mutant proteins are loss-of-function and dominant-negative when tested following overproduction in recipient cells. However, the production of mutant proteins has not been detected and quantified in the cells of heterozygous patients. We report a deep intronic heterozygous STAT3 mutation, c.1282-89C>T, in 7 relatives with AD HIES. This mutation creates a new exon in the STAT3 complementary DNA, which, when overexpressed, generates a mutant STAT3 protein (D427ins17) that is loss-of-function and dominant-negative in terms of tyrosine phosphorylation, DNA binding, and transcriptional activity. In immortalized B cells from these patients, the D427ins17 protein was 2 kDa larger and 4-fold less abundant than wild-type STAT3, on mass spectrometry. The patients' primary B and T lymphocytes responded poorly to STAT3-dependent cytokines. These findings are reminiscent of the impaired responses of leukocytes from other patients with AD HIES due to typical STAT3 coding mutations, providing further evidence for the dominance of the mutant intronic allele. These findings highlight the importance of sequencing STAT3 introns in patients with HIES without candidate variants in coding regions and essential splice sites. They also show that AD HIES-causing STAT3 mutant alleles can be dominant-negative even if the encoded protein is produced in significantly smaller amounts than wild-type STAT3.

Entities:  

Keywords:  STAT3; dominant negative; hyper IgE syndrome; immunodeficiency; infectious diseases

Year:  2019        PMID: 31346092      PMCID: PMC6697804          DOI: 10.1073/pnas.1901409116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  92 in total

1.  GeneSplicer: a new computational method for splice site prediction.

Authors:  M Pertea; X Lin; S L Salzberg
Journal:  Nucleic Acids Res       Date:  2001-03-01       Impact factor: 16.971

Review 2.  Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease.

Authors:  Mehrdad Khajavi; Ken Inoue; James R Lupski
Journal:  Eur J Hum Genet       Date:  2006-06-07       Impact factor: 4.246

3.  Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome.

Authors:  Yoshiyuki Minegishi; Masako Saito; Shigeru Tsuchiya; Ikuya Tsuge; Hidetoshi Takada; Toshiro Hara; Nobuaki Kawamura; Tadashi Ariga; Srdjan Pasic; Oliver Stojkovic; Ayse Metin; Hajime Karasuyama
Journal:  Nature       Date:  2007-08-05       Impact factor: 49.962

Review 4.  JAK-STAT signaling: from interferons to cytokines.

Authors:  Christian Schindler; David E Levy; Thomas Decker
Journal:  J Biol Chem       Date:  2007-05-14       Impact factor: 5.157

5.  Bone marrow transplantation does not correct the hyper IgE syndrome.

Authors:  A R Gennery; T J Flood; M Abinun; A J Cant
Journal:  Bone Marrow Transplant       Date:  2000-06       Impact factor: 5.483

6.  Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder.

Authors:  B Grimbacher; S M Holland; J I Gallin; F Greenberg; S C Hill; H L Malech; J A Miller; A C O'Connell; J M Puck
Journal:  N Engl J Med       Date:  1999-03-04       Impact factor: 91.245

Review 7.  Human tyk2 kinase deficiency: another primary immunodeficiency syndrome.

Authors:  Wendy T Watford; John J O'Shea
Journal:  Immunity       Date:  2006-11       Impact factor: 31.745

8.  Stat3 isoforms, alpha and beta, demonstrate distinct intracellular dynamics with prolonged nuclear retention of Stat3beta mapping to its unique C-terminal end.

Authors:  Ying Huang; Jihui Qiu; Shuo Dong; Michele S Redell; Valeria Poli; Michael A Mancini; David J Tweardy
Journal:  J Biol Chem       Date:  2007-09-12       Impact factor: 5.157

9.  ESEfinder: A web resource to identify exonic splicing enhancers.

Authors:  Luca Cartegni; Jinhua Wang; Zhengwei Zhu; Michael Q Zhang; Adrian R Krainer
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

10.  The STAT3 isoforms alpha and beta have unique and specific functions.

Authors:  Diego Maritano; Michelle L Sugrue; Silvia Tininini; Sarah Dewilde; Birgit Strobl; XinPing Fu; Victoria Murray-Tait; Roberto Chiarle; Valeria Poli
Journal:  Nat Immunol       Date:  2004-03-14       Impact factor: 25.606

View more
  11 in total

Review 1.  An appraisal of the Wilson & Jungner criteria in the context of genomic-based newborn screening for inborn errors of immunity.

Authors:  Jovanka R King; Luigi D Notarangelo; Lennart Hammarström
Journal:  J Allergy Clin Immunol       Date:  2021-02       Impact factor: 10.793

2.  Hyper-IgE Syndrome due to an Elusive Novel Intronic Homozygous Variant in DOCK8.

Authors:  Paul E Gray; Bethany A Pillay; Stuart G Tangye; Jin Yan Yap; William A Figgett; John Reeves; Sarah K Kummerfeld; Jennifer Stoddard; Gulbu Uzel; Huie Jing; Helen C Su; Dianne E Campbell; Anna Sullivan; Leslie Burnett; Jane Peake; Cindy S Ma
Journal:  J Clin Immunol       Date:  2021-10-17       Impact factor: 8.542

Review 3.  AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer-a Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI).

Authors:  D Ferastraoaru; H J Bax; C Bergmann; M Capron; M Castells; D Dombrowicz; E Fiebiger; H J Gould; K Hartmann; U Jappe; G Jordakieva; D H Josephs; F Levi-Schaffer; V Mahler; A Poli; D Rosenstreich; F Roth-Walter; M Shamji; E H Steveling-Klein; M C Turner; E Untersmayr; S N Karagiannis; E Jensen-Jarolim
Journal:  Clin Transl Allergy       Date:  2020-07-17       Impact factor: 5.871

4.  Genetic variation and fungal infection risk: State of the art.

Authors:  Michail S Lionakis
Journal:  Curr Fungal Infect Rep       Date:  2019-11-27

Review 5.  STAT3 Hyper-IgE Syndrome-an Update and Unanswered Questions.

Authors:  Christo Tsilifis; Alexandra F Freeman; Andrew R Gennery
Journal:  J Clin Immunol       Date:  2021-05-01       Impact factor: 8.317

6.  Human STAT3 variants underlie autosomal dominant hyper-IgE syndrome by negative dominance.

Authors:  Joëlle Khourieh; Peng Zhang; Franck Rapaport; Qian Zhang; Anne Puel; Vivien Béziat; Jean-Laurent Casanova; Bertrand Boisson; Takaki Asano; András N Spaan; Juan Li; Wei-Te Lei; Simon J Pelham; David Hum; Maya Chrabieh; Ji Eun Han; Antoine Guérin; Joseph Mackie; Sudhir Gupta; Biman Saikia; Jamila E I Baghdadi; Ilham Fadil; Aziz Bousfiha; Tanwir Habib; Nico Marr; Luckshman Ganeshanandan; Jane Peake; Luke Droney; Andrew Williams; Fatih Celmeli; Nevin Hatipoglu; Tayfun Ozcelik; Capucine Picard; Laurent Abel; Stuart G Tangye; Stéphanie Boisson-Dupuis
Journal:  J Exp Med       Date:  2021-06-17       Impact factor: 14.307

Review 7.  Recent advances in primary immunodeficiency: from molecular diagnosis to treatment.

Authors:  Giorgia Bucciol; Isabelle Meyts
Journal:  F1000Res       Date:  2020-03-19

8.  Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome.

Authors:  Vivien Béziat; Simon J Tavernier; Yin-Huai Chen; Cindy S Ma; Marie Materna; Arian Laurence; Jens Staal; Dominik Aschenbrenner; Lisa Roels; Lisa Worley; Kathleen Claes; Lisa Gartner; Lisa A Kohn; Marieke De Bruyne; Klaus Schmitz-Abe; Louis-Marie Charbonnier; Sevgi Keles; Justine Nammour; Natasha Vladikine; Majistor Raj Luxman Maglorius Renkilaraj; Yoann Seeleuthner; Mélanie Migaud; Jérémie Rosain; Mohamed Jeljeli; Bertrand Boisson; Eva Van Braeckel; Jill A Rosenfeld; Hongzheng Dai; Lindsay C Burrage; David R Murdock; Bart N Lambrecht; Véronique Avettand-Fenoel; Tiphanie P Vogel; Charles R Esther; Sule Haskologlu; Figen Dogu; Peter Ciznar; David Boutboul; Marie Ouachée-Chardin; Jean Amourette; Marie-Noëlle Lebras; Clément Gauvain; Colas Tcherakian; Aydan Ikinciogullari; Rudi Beyaert; Laurent Abel; Joshua D Milner; Bodo Grimbacher; Louis-Jean Couderc; Manish J Butte; Alexandra F Freeman; Émilie Catherinot; Claire Fieschi; Talal A Chatila; Stuart G Tangye; Holm H Uhlig; Filomeen Haerynck; Jean-Laurent Casanova; Anne Puel
Journal:  J Exp Med       Date:  2020-06-01       Impact factor: 14.307

Review 9.  Inborn errors of IL-6 family cytokine responses.

Authors:  Yin-Huai Chen; Sarah Spencer; Arian Laurence; James Ed Thaventhiran; Holm H Uhlig
Journal:  Curr Opin Immunol       Date:  2021-05-24       Impact factor: 7.268

10.  STAT3 deficiency in B cells exacerbates uveitis by promoting expansion of pathogenic lymphocytes and suppressing regulatory B cells (Bregs) and Tregs.

Authors:  Favour O Oladipupo; Cheng-Rong Yu; Ezekiel Olumuyide; Yingyos Jittaysothorn; Jin Kyeong Choi; Charles E Egwuagu
Journal:  Sci Rep       Date:  2020-10-01       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.